ARIA/Takeda—Regarding the "Are you still committed to R&D in Japan?" question, it reminds me of the same question posed to the then CEO of Sanofi when he did the Warp Drive deal.
I'm pretty sure the question came from a member of the Japanese news media rather than an investment analyst. It's a reminder that concerns about globalism are not limited to the US and EU.
Biomaven, thanks for helping me develop the conviction to hold on to ARIA.
Eerily, the Brigatinib comments on Takeda's CC by CSO/CMO Andrew Plumb were almost xerox copies of blurbs Peter has written on this board and elsewhere.